Publication Name	World Journal of Gastroenterology
Manuscript ID	9705
Country	China

Received	2014-02-24 14:52
Peer-Review Started	2014-02-24 16:59
To Make the First Decision	2014-03-27 20:55
Return for Revision	2014-03-31 10:23
Revised	2014-05-29 00:00
Second Decision	2014-07-11 17:02
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-07-11 17:16
Articles in Press	2014-07-11 17:34
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-07-17 16:37
Typeset the Manuscript	2014-11-18 13:50
Publish the Manuscript Online	2014-12-10 15:52

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Autobiography
Article Title	Inhibitory effects of dobutamine on human gastric adenocarcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Hui-Xia Zheng, Li-Na Wu, Hong Xiao, Qian Du and Jian-Fang Liang
Funding Agency and Grant Number
Corresponding Author	Jian-Fang Liang, MD, Chief Physician, Department of Pathology, The First Hospital, Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan 030024, Shanxi Province, China. liangjianfang2000@163.com
Key Words	Dobutamine; Gastric adenocarcinoma cells; Yes-associated protein; Hippo pathway; Human gastric adenocarcinoma cell line SGC-7901; Therapy
Core Tip	Dobutamine inhibited the viability, migration, proliferation and invasion of SGC-7901 cells. Dobutamine arrested the cell cycle at G1/S phase, and increased the rate of apoptosis of gastric adenocarcinoma cells. Phosphorylated Yes-associated protein was found mainly in the cytosol after treatment with dobutamine.
Publish Date	2014-12-10 15:52
Citation	Zheng HX, Wu LN, Xiao H, Du Q, Liang JF. Inhibitory effects of dobutamine on human gastric adenocarcinoma. World J Gastroenterol 2014; 20(45): 17092-17099
URL	http://www.wjgnet.com/1007-9327/full/v20/i45/17092.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i45.17092

Full Article (PDF)	WJG-20-17092.pdf
Full Article (Word)	WJG-20-17092.doc
Manuscript File	9705-Review.doc
Answering Reviewers	9705-Answering Reviewers.pdf
Copyright License Agreement	9705-Copyright Assignment.pdf
Non-Native Speakers of English Editing Certificate	9705-Language certificate.PDF
Peer-review Report	9705-Peer review.pdf
Scientific Misconduct Check	9705-CrossCheck.jpg
Scientific Editor Work List	9705-Scientific editor work list.pdf